Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
This study was undertaken to examine the experiences and perspectives of Indigenous Peoples who use illicit drugs (IPWUID) in the Downtown Eastside of Vancouver regarding the drug poisoning crisis
The current qualitative study examines the perspectives of women with opioid use disorder (OUD) and professionals that serve them on barriers to engaging in overdose prevention and harm reduction p
Drugs sold on cryptomarkets are thought to have lower levels of adulteration and higher strength compared with those sourced off-line.
The Community Urinalysis and Self-Report Project (CUSP) is a low-barrier sentinel surveillance system developed to better understand use of drugs from the unregulated supply.
Is compulsory unpaid labor essential addiction “therapy” or unjust exploitation?
In an Indigenous Health Service hospital in rural Minnesota, the pharmacy sought to integrate harm reduction and express Sexually Transmitted Infections (STIs) services into its scope of practice.
The number of overdose deaths since 1999 has steadily increased in large part due to the presence of synthetic opioids in the US drug supply.
Safer supply programs are intended to reduce overdose events by limiting people's use of the contaminated drug supply, but the experiences of people receiving hydromorphone vary.
This study aimed to estimate the risk of opioid-related poisonings and mental and behavioural disorders by occupation and industry within a cohort of 1.7 million formerly injured workers.
In the US context of an unprecedented magnitude of drug overdose deaths and during the fentanyl era, it becomes increasingly imperative to identify longitudinal predictors to inform targeted preven
To assess the risk of treatment discontinuation and mortality among individuals receiving buprenorphine/naloxone vs methadone for the treatment of opioid use disorder.
This study aimed to estimate the strength of association between prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 RA) and
To assess the 2-year layperson-administered naloxone (LAN) trend for persons in the United States receiving naloxone during emergency medical services (EMS) activations.
This guide provides information and strategies to primary care providers on harm reduction as a trauma informed approach to treating individuals with substance use disorder.
This study examined how and why primary care systems may be suited towards, or pose challenges to providing OUD care, and identified health system opportunities to address these challenges.
Literature, best practices and media narratives can be readily found for people with substance use disorders (SUD), however much less is known across Canada about how to support the substance use h
In the province of Alberta, new regulations introduced in 2022 significantly constrain safer supply prescribing by banning the prescription, dispensing, and administration of safer supply outside o
This scoping review synthesizes barriers and facilitators to buprenorphine initiation in the ED, and uses the Consolidated Framework for Implementation Research and a critical lens to analyze the l
This lab-based study aimed at evaluating lateral flow immunoassay nitazene test strips (NTS; BTNX Rapid Response™) for their potential in drug checking applications.
Conceptualizing the Emergency Department (ED) as a complex adaptive system, this paper examines how ED staff experience opioid-specific harm reduction provision and engage in harm reduction practic